Pharmacokinetics of cefotaxime in intensive care patients: exploration of the sources of variability with a population model - Archive ouverte HAL Accéder directement au contenu
Communication Dans Un Congrès Année : 2023

Pharmacokinetics of cefotaxime in intensive care patients: exploration of the sources of variability with a population model

Résumé

Background : Cefotaxime is a beta-lactam antibiotics commonly used in intensive care unit (ICU) patients. In this population, pathophysiological modifications induce a high inter- and intra-individual pharmacokinetic variability which can result in supra or sub-therapeutic concentrations of cefotaxime. Indeed, it has recently been shown that the risk of not meeting the PK/PD target was particularly high with cefotaxime in ICU patients1. To date, only one population PK study has been performed in this context2. A better understanding of the sources and correlates of PK variability in ICU patients is then required to perform cefotaxime a priori dose adjustment.
Fichier principal
Vignette du fichier
poster_anthea_deschamps.pdf (858.78 Ko) Télécharger le fichier
Origine Fichiers produits par l'(les) auteur(s)

Dates et versions

hal-04353098 , version 1 (19-12-2023)

Identifiants

  • HAL Id : hal-04353098 , version 1

Citer

Anthea Deschamps, Lionel Velly, Elisabeth Jouve, Romain Guilhaumou, Florence Gattacceca. Pharmacokinetics of cefotaxime in intensive care patients: exploration of the sources of variability with a population model. PAGE 2023 - 31th Annual Meeting of the Population Approach Group in Europe, Jun 2023, La Corogne, Spain. pp.10667. ⟨hal-04353098⟩
28 Consultations
12 Téléchargements

Partager

Gmail Mastodon Facebook X LinkedIn More